The Traderszone Network

Published in TZ Latest News 20 April, 2015 by The TZ Newswire Staff

Is Bristol-Myers Squibb. Co. About to Fall Apart?

Bristol-Myers Squibb is pinning its future on a new class of drugs that could be game-changers in the fight against cancer. The Street, though, may be wildly overestimating their commercial potential. Here’s why.